Home › Ulcerative Colitis › Arkansas › Little Rock
Ulcerative Colitis clinical trials in Little Rock, AR
4 studies for Ulcerative Colitis are looking for participants at sites in and around Little Rock (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Applied Research Center of Arkansas, Little Rock
- Preferred Research Partners, Little Rock
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 3
- Preferred Research Partners - Site Number: 8400018, Little Rock
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
RecruitingPhase 2
- Arkansas Children's (IP Address), Little Rock
- Arkansas Children's, Little Rock
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RecruitingPhase 2
- Mirador Therapeutics Selected Site, Little Rock
- Mirador Therapeutics Selected Site, Little Rock
About Ulcerative Colitis
Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.
More about Ulcerative Colitis on MedlinePlus
Ulcerative Colitis trials in other cities
- New York City, NY24 studies
- Orlando, FL23 studies
- Miami, FL22 studies
- Houston, TX18 studies
- San Antonio, TX16 studies
- San Diego, CA16 studies
- Tacoma, WA15 studies
- Chicago, IL15 studies
- Colorado Springs, CO14 studies
- St. Louis, MO14 studies
- Tyler, TX14 studies
- Los Angeles, CA13 studies
Other studies in Little Rock
- Schizophrenia19 studies
- Cancer (all types)15 studies
- Major Depressive Disorder14 studies
- Acute Myeloid Leukemia13 studies
- Non-Small Cell Lung Cancer13 studies
- Endometrial Cancer11 studies
- Obesity11 studies
- Depression10 studies
- Type 2 Diabetes10 studies
- Cardiovascular Disease9 studies
- Bladder Cancer9 studies
- Lung Cancer9 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.